Sclerosing Polycystic Adenoma: Conclusive Clinical and Molecular Evidence of Its Neoplastic Nature

Keyphrases

• Sclerosing Polycystic Adenoma 100%
• Tumor 60%
• Neoplasms 40%
• Immunohistochemistry 40%
• PIK3CA 40%
• Cyst 40%
• Next-generation Sequencing 40%
• PI3K Pathway 40%
• Acinar Cells 40%
• Cowden Syndrome 40%
• Apocrine 40%
• High Prevalence 20%
• Moderate to Severe 20%
• Genetic Modification 20%
• Genetic Counseling 20%
• Non-neoplastic 20%
• Atypia 20%
• Adenopathy 20%
• Salivary Duct Carcinoma 20%
• Neck Tumor 20%
• Parotid Gland 20%
• Cell Lining 20%
• Malignant Transformation 20%
• Sclerotic 20%
• Acinus 20%
• Adenoma 20%
• Intracytoplasmic 20%
• Pathway Alteration 20%
• PIK3R1 20%
• Nuclear Expression 20%
• PTEN mutation 20%
• Germline Genetic Testing 20%
• PTEN Expression 20%
• Ductal Cells 20%
• Oncogenic Alterations 20%
• Salivary Gland Lesions 20%
• Myoepithelial Cells 20%
• Multiple Recurrence 20%
• Eosinophilic Granules 20%
• Intraductal Carcinoma 20%
• Germline Testing 20%
• 2017 WHO Classification 20%
• Atypical Intraductal Proliferation 20%
• Sclerosing Polycystic Adenosis 20%

Medicine and Dentistry

• Adenoma 100%
• Tumor 50%
• Recurrent Disease 33%
• Neoplasm 33%
• Immunohistochemistry 33%
• Stroma 33%
• Cowden Syndrome 33%
• Next Generation Sequencing 33%
• Adenosis 33%
• Germ Cell 33%
• Prevalence 16%
• Carcinogenesis 16%
• Morphology 16%
• Acinar Cell 16%
• Genetic Counseling 16%
• Salivary Duct Carcinoma 16%
• Head and Neck Tumor 16%
• Gene Mutation 16%
• Malignant Transformation 16%
• Genetic Screening 16%
• Acinus 16%
• Eosinophilic 16%
• Parotid Gland 16%
• Intraductal Carcinoma 16%
• Salivary Gland Disease 16%